Adage Capital Partners’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-365,198
| Closed | -$2.13M | – | 913 |
|
|
2024
Q4 | $2.13M | Sell |
365,198
-34,802
| -9% | -$203K | ﹤0.01% | 788 |
|
|
2024
Q3 | $4.78M | Buy |
400,000
+75,000
| +23% | +$896K | 0.01% | 719 |
|
|
2024
Q2 | $3.52M | Sell |
325,000
-135,000
| -29% | -$1.46M | 0.01% | 743 |
|
|
2024
Q1 | $5.21M | Sell |
460,000
-40,000
| -8% | -$453K | 0.01% | 693 |
|
|
2023
Q4 | $7.02M | Buy |
500,000
+111,018
| +29% | +$1.56M | 0.01% | 649 |
|
|
2023
Q3 | $4.8M | Buy |
388,982
+157,549
| +68% | +$1.95M | 0.01% | 666 |
|
|
2023
Q2 | $2.09M | Sell |
231,433
-188,567
| -45% | -$1.7M | ﹤0.01% | 737 |
|
|
2023
Q1 | $1.46M | Hold |
420,000
| – | – | ﹤0.01% | 785 |
|
|
2022
Q4 | $1.03M | Hold |
420,000
| – | – | ﹤0.01% | 840 |
|
|
2022
Q3 | $1.16M | Sell |
420,000
-80,000
| -16% | -$221K | ﹤0.01% | 884 |
|
|
2022
Q2 | $2.04M | Buy |
500,000
+411,203
| +463% | +$1.67M | ﹤0.01% | 878 |
|
|
2022
Q1 | $378K | Buy |
+88,797
| New | +$378K | ﹤0.01% | 966 |
|
|
2021
Q3 | – | Sell |
-225,000
| Closed | -$6.3M | – | 1051 |
|
|
2021
Q2 | $6.3M | Buy |
+225,000
| New | +$6.3M | 0.01% | 790 |
|